Malika Almansouri is currently the Regulatory Affairs Africa & Middle East Lead at the Coalition for Epidemic Preparedness Innovations (CEPI) since May 2021. Prior experience includes a significant tenure at GlaxoSmithKline (January 2002 - March 2021), where roles ranged from Regulatory Affairs Regional Expert to Project Manager, focusing on regulatory submissions for paediatric vaccines in the European Union and rest of the world. Additional positions held include RA Clinical Scientist and RA CMC Scientist, along with work as a Statistician Consultant for SPS Europe. Earlier experience includes a SAS Consultant role at UCB and Project Manager at CARI asbl in 1999. Malika holds an MBA from Louvain School of Management and a PhD in Biology from Université catholique de Louvain.